184 related articles for article (PubMed ID: 33893331)
21. Too much of a good thing? Experimental evidence suggests prolonged exposure to hCG is detrimental to endometrial receptivity.
Evans J; Salamonsen LA
Hum Reprod; 2013 Jun; 28(6):1610-9. PubMed ID: 23515188
[TBL] [Abstract][Full Text] [Related]
22. Prostaglandin E1 (PGE1), but not prostaglandin E2 (PGE2), alters luteal and endometrial luteinizing hormone (LH) occupied and unoccupied LH receptors and mRNA for LH receptors in ovine luteal tissue to prevent luteolysis.
Weems YS; Nett TM; Rispoli LA; Davis TL; Johnson DL; Uchima T; Raney A; Lennon E; Pang J; Harbert T; Bowers G; Goto K; Ong A; Tsutahara N; Randel RD; Weems CW
Prostaglandins Other Lipid Mediat; 2010 Feb; 91(1-2):42-50. PubMed ID: 20060488
[TBL] [Abstract][Full Text] [Related]
23. A novel post-transcriptional mechanism of regulation of luteinizing hormone receptor expression by an RNA binding protein from the ovary.
Menon KM; Nair AK; Wang L
Mol Cell Endocrinol; 2006 Feb; 246(1-2):135-41. PubMed ID: 16406262
[TBL] [Abstract][Full Text] [Related]
24. Long-term label retaining cells localize to distinct regions within the female reproductive epithelium.
Patterson AL; Pru JK
Cell Cycle; 2013 Sep; 12(17):2888-98. PubMed ID: 24018418
[TBL] [Abstract][Full Text] [Related]
25. Increased expression of human luteinizing hormone/human chorionic gonadotropin receptor mRNA in human endometrial cancer.
Ji Q; Chen P; Aoyoma C; Liu P
Mol Cell Probes; 2002 Aug; 16(4):269-75. PubMed ID: 12270268
[TBL] [Abstract][Full Text] [Related]
26. Assessment of luteinizing hormone receptor function in an endometrial cancer cell line, Ishikawa cells in response to human chorionic gonadotrophin (hCG).
Viswanath G; Chatterjee S; Roy P
Mol Cell Endocrinol; 2007 Jun; 272(1-2):14-21. PubMed ID: 17548147
[TBL] [Abstract][Full Text] [Related]
27. Potentiation of diethylstilbestrol-induced alterations in the female mouse reproductive tract by transforming growth factor-alpha transgene expression.
Gray K; Bullock B; Dickson R; Raszmann K; Walmer D; McLachlan J; Merlino G
Mol Carcinog; 1996 Nov; 17(3):163-73. PubMed ID: 8944077
[TBL] [Abstract][Full Text] [Related]
28. Luteinizing Hormone and GATA4 Action in the Adrenocortical Tumorigenesis of Gonadectomized Female Mice.
Doroszko M; Chrusciel M; Stelmaszewska J; Slezak T; Rivero-Muller A; Padzik A; Anisimowicz S; Wolczynski S; Huhtaniemi I; Toppari J; Rahman NA
Cell Physiol Biochem; 2017; 43(3):1064-1076. PubMed ID: 28977799
[TBL] [Abstract][Full Text] [Related]
29. Nongonadal LH receptors, their involvement in female reproductive function and a new applicable approach.
Ziecik AJ; Bodek G; Blitek A; Kaczmarek M; Waclawik A
Vet J; 2005 Jan; 169(1):75-84. PubMed ID: 15683766
[TBL] [Abstract][Full Text] [Related]
30. Increased expression of LH/hCG receptors in endometrial hyperplasia and carcinoma in anovulatory women.
Konishi I; Koshiyama M; Mandai M; Kuroda H; Yamamoto S; Nanbu K; Komatsu T; Matsushita K; Rao CV; Mori T
Gynecol Oncol; 1997 May; 65(2):273-80. PubMed ID: 9159337
[TBL] [Abstract][Full Text] [Related]
31. Consequences of targeted inactivation of LH receptors.
Rao CV; Lei ZM
Mol Cell Endocrinol; 2002 Feb; 187(1-2):57-67. PubMed ID: 11988312
[TBL] [Abstract][Full Text] [Related]
32. Homologous down-regulation of luteinizing hormone/chorionic gonadotropin receptors by increasing the degradation of receptor transcripts in human uterine endometrial stromal cells.
Han SW; Lei ZM; Rao CV
Biol Reprod; 1997 Jul; 57(1):158-64. PubMed ID: 9209094
[TBL] [Abstract][Full Text] [Related]
33. Development of cystic glandular hyperplasia of the endometrium in Mullerian inhibitory substance type II receptor-pituitary tumor transforming gene transgenic mice.
El-Naggar SM; Malik MT; Martin A; Moore JP; Proctor M; Hamid T; Kakar SS
J Endocrinol; 2007 Jul; 194(1):179-91. PubMed ID: 17592032
[TBL] [Abstract][Full Text] [Related]
34. Expression of functional luteinizing hormone (LH) receptor and its messenger ribonucleic acid in bovine endometrium: LH augmentation of cAMP and inositol phosphate in vitro and human chorionic gonadotropin (hCG) augmentation of peripheral prostaglandin in vivo.
Shemesh M; Mizrachi D; Gurevich M; Shore LS; Reed J; Chang SM; Thatcher WW; Fields MJ
Reprod Biol; 2001 Nov; 1(2):13-32. PubMed ID: 14666165
[TBL] [Abstract][Full Text] [Related]
35. Luteinizing hormone affects uterine receptivity independently of ovarian function.
Tesarik J; Hazout A; Mendoza C
Reprod Biomed Online; 2003; 7(1):59-64. PubMed ID: 12930575
[TBL] [Abstract][Full Text] [Related]
36. Genetically modified mouse models addressing gonadotropin function.
Ratner LD; Rulli SB; Huhtaniemi IT
Reprod Biol; 2014 Mar; 14(1):9-15. PubMed ID: 24607250
[TBL] [Abstract][Full Text] [Related]
37. Extragonadal gonadotropin receptors, their distribution and function.
Ziecik AJ; Derecka-Reszka K; Rzucidło SJ
J Physiol Pharmacol; 1992 Dec; 43(4 Suppl 1):33-49. PubMed ID: 1343973
[TBL] [Abstract][Full Text] [Related]
38. Targeted therapy for adrenocortical tumors in transgenic mice through their LH receptor by Hecate-human chorionic gonadotropin beta conjugate.
Vuorenoja S; Rivero-Müller A; Ziecik AJ; Huhtaniemi I; Toppari J; Rahman NA
Endocr Relat Cancer; 2008 Jun; 15(2):635-48. PubMed ID: 18509010
[TBL] [Abstract][Full Text] [Related]
39. Adrenocortical tumorigenesis in transgenic mice: the role of luteinizing hormone receptor and transcription factors GATA-4 and GATA-61.
Rahman NA; Kiiveri S; Siltanen S; Levallet J; Kero J; Lensu T; Wilson DB; Heikinheimo MT; Huhtaniemi IT
Reprod Biol; 2001 Jul; 1(1):5-9. PubMed ID: 14666170
[TBL] [Abstract][Full Text] [Related]
40. Transgenic GATA-4 expression induces adrenocortical tumorigenesis in C57Bl/6 mice.
Chrusciel M; Vuorenoja S; Mohanty B; Rivero-Müller A; Li X; Toppari J; Huhtaniemi I; Rahman NA
J Cell Sci; 2013 Apr; 126(Pt 8):1845-57. PubMed ID: 23444372
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
